Related Experiment Video
Updated: Apr 15, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Biventricular pacemakers in patients with heart failure
1Karen Leslie Cooper is a clinical nurse specialist at Sutter Auburn Faith Hospital, Auburn, California. k4r3n@surewest.net.
Insights
Biventricular pacemakers can help heart failure patients. These devices require more frequent and thorough patient assessments compared to traditional pacemakers.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Heart failure (HF) is a complex condition impacting millions globally.
- Traditional pacemakers manage heart rhythm but may not fully address HF symptoms.
- Biventricular pacing offers a potential therapeutic option for select HF patients.
Observation:
- This article reviews the clinical indications for biventricular pacemaker (BVP) implantation.
- It details the comprehensive assessment protocols necessary for patients receiving BVPs.
- Specialized evaluation is crucial for optimizing BVP therapy.
Findings:
- Biventricular pacemakers are indicated for specific heart failure patient profiles.
- Patient selection and ongoing monitoring are key components of successful BVP therapy.
- The assessment process for BVPs is more extensive than for conventional pacemakers.
Implications:
- Optimized BVP implantation and management can improve heart failure outcomes.
- Enhanced patient assessment ensures appropriate device utilization and efficacy.
- This approach highlights the evolving role of cardiac device therapy in heart failure management.
Abstract:
Patients with heart failure may benefit from implantation of a biventricular pacemaker. This article discusses the indications for biventricular pacemaker implantation and the assessment of patients with biventricular pacemakers. Biventricular pacemakers require more assessments than do traditional single- or dual-chamber pacemakers.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure V: Medical Management
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care

